iquid biopsies for personalized cancer therapy of rectal cancer - Kolibri

niversitätsklinikum Carl Gustav Carus0 个研究点目标入组 166 人开始时间: 2016年3月10日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•- advanced rectal cancer
•- neoadjuvant radiochemotherapy
•- cT3 / cT4, cN0 cM0 / 1 or any cN + indep. from T and M Status
•- paraffin block from the diagnostic biopsy material and from the surgery preparation available in pathology and for scientific investigation
•- imaging examination before surgery available
•- surgery report and written histology finding available
•- performance status WHO 0-2
•- tumor volume and location allow curative radiochemotherapy
•- Age = 18 years
•- advanced rectal cancer
•- neoadjuvant radiochemotherapy
•- prescribed dose: 25 Gy à 5 Gy / fraction
•- cT3 / cT4, cN0 cM0 / 1 or any cN + indep. from T and M status
•- paraffin block from the diagnostic biopsy material and from the surgery preparation available in pathology and for scientific investigation
•- imaging examination before surgery available
•- surgery report and written histology finding available
•- performance status WHO 0-2
•- Age = 18 years

•- other tumor disease that requires therapy or influences probability of survival of the patient
•- tumor independent diseases or conditions which reduce the probability of survival of the patient to < 2 years
•- previous irradiation in the pelvic area
•- pregnancy
•- lack of understanding or lack of cooperation

发起方

niversitätsklinikum Carl Gustav Carus